Submit a Manuscript
F6Publishing
Publisher Login
Manuscript Statistics
Articles In Press
1
Pannirselvam M, Zakaria Z, Wong MPK, Abdul Satar MHS, Jusoh NS, Zakaria AD, Othman MF. Effects of preoperative immunonutrition vs standard oral nutrition in patients undergoing colorectal surgery: A randomized controlled trial. World J Gastrointest Surg 2025; In press
2025-07-31 | Browse: 0 | Download: 0
2
Ilhan E, Okut G. Double tract reconstruction in proximal gastric tumors: A systematic review of clinical and functional outcomes. World J Gastrointest Surg 2025; In press
2025-07-31 | Browse: 0 | Download: 0
3
Wu D, Wang J. Impact of enhanced recovery after surgery on postoperative pain management and functional recovery in patients with colorectal cancer. World J Gastrointest Surg 2025; In press
2025-07-31 | Browse: 0 | Download: 0
4
Huang YH, Ma L, Cao B, Zhang YJ, Gao Q, Zhu ZM, Qiao XL, Wang L, He BG. Endoscopic and laparoscopic treatment of ileocecal laterally spreading tumor with concomitant appendiceal adenoma: A case report and review of literature. World J Gastrointest Surg 2025; In press
2025-07-31 | Browse: 0 | Download: 0
5
Ahunayizhi A, Zhang XL, Chen Q, Wang H, Ding G, Akumuo S, Wang XX, Ruan XJ. Laparoscopic management of gallstones in a duplicate gallbladder with double cystic ducts: A case report. World J Gastrointest Surg 2025; In press
2025-07-31 | Browse: 0 | Download: 0
6
Pan SD, Xiong CY, Shen YJ, Tian JH, Wang YL, Wang JN, Wang SY, Li FY, Wang LF, Qiu Q, Yang L, Liu XM, Luan JQ, Zou ZS, Wang FS, Meng FP. MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acid. World J Gastroenterol 2025; In press
2025-07-31 | Browse: 2 | Download: 0
7
Chen Y, Tang WL, Li CT, Zhao Y, Li B, Liao LM, Lin TH, Zhang LC. Efficacy and safety of different doses of dexmedetomidine on gastrointestinal function recovery after laparoscopic colorectal surgery. World J Gastroenterol 2025; In press
2025-07-31 | Browse: 2 | Download: 0
8
Liu SQ, Wang D, Tang CC. Current status and mechanistic insights into nontarget coronary lesions in patients with diabetes and early abnormal glucose metabolism. World J Diabetes 2025; In press
2025-07-30 | Browse: 4 | Download: 0
9
Yang JQ, Wu J, Guo JE, Yang ZX, Liu JY, Wang YM, Zhang YJ. Neck pain and emotional state in cervical spondylosis: A dual trajectory model analysis. World J Psychiatry 2025; In press
2025-07-30 | Browse: 2 | Download: 0
10
Dong L. Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies. World J Psychiatry 2025; In press
2025-07-30 | Browse: 3 | Download: 0
11
Liu HM, Zhang X, Huang HY, Sun JM, Tong QD. Comparative impact of antiviral therapies on postoperative recurrence risk in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastrointest Oncol 2025; In press
2025-07-30 | Browse: 2 | Download: 0
12
Wang DE, Qin XF, Yang W. Correlation between sarcopenia diagnosed by C3SMI criteria and prognosis in esophageal cancer patients after radiotherapy. World J Gastrointest Oncol 2025; In press
2025-07-30 | Browse: 2 | Download: 0
13
Zhang X, Chen DB, Zhang R, Chen P, She SP, Yang Y, Ren LY, Chen HS. Immune checkpoint molecules signal regulatory protein alpha in the development of hepatocellular carcinoma. World J Gastrointest Oncol 2025; In press
2025-07-30 | Browse: 3 | Download: 0
14
Chen ZH, Zhang LJ, Lin ZX, Lin SX, Song ZF, Wu ZJ, Lin W. Safety and efficacy of three-dimensional reconstruction technology-assisted percutaneous transhepatic biliary drainage: A meta-analysis. World J Gastrointest Surg 2025; In press
2025-07-30 | Browse: 3 | Download: 0
15
Ji DH, Guan ZA. Evaluation of efficacy and safety of different endoscopic polypectomy techniques for colonic polyps. World J Gastrointest Surg 2025; In press
2025-07-30 | Browse: 2 | Download: 0
16
Koriem KMM. Duodenal mucosal ablation with irreversible electroporation in non-alcoholic fatty liver disease: Roadmap of the future treatment. World J Gastroenterol 2025; In press
2025-07-30 | Browse: 2 | Download: 0
17
AlKhateb B, Alkhateb O, Daaboul B. Metformin abuse and weight loss: A case report. World J Clin Cases 2025; In press
2025-07-29 | Browse: 5 | Download: 0
18
Senchukova MA, Saidler NV, Zubareva EY, Prokofiev AB, Tagabilev DG. Concordance of programmed death-ligand 1 expression assessments determined via two immunohistochemical tests and the polymerase chain reaction method. World J Exp Med 2025; In press
2025-07-29 | Browse: 7 | Download: 0
19
Petrovic I, Brekalo K, Romic I, Silovski H, Sesa V, Galunic Cicak R, Bulic K, Koltay OM, Strajher I, Mrzljak A. Tissue expanders - an innovative approach in the management of hepatic venous outflow obstruction after liver transplantation: A case report. World J Clin Cases 2025; In press
2025-07-29 | Browse: 7 | Download: 0
20
Alam F, Siddiqui H, Nihal A, Andleeb M, Zaman AQU, Khushk MI, Husain F, Rai R, Fatima FB, Kumar D, Rizvi SAFA, Jabeen S, Jawed I, Qadir U, Zakeri MA. Advancing multiple myeloma therapy: A systematic analysis of corticosteroids and monoclonal antibodies as dual therapeutic agents. World J Methodol 2025; In press
2025-07-29 | Browse: 11 | Download: 0
627 items  Read more >>
Author Reviews
1
"It is very interesting to summarize the data in the work and publish scientific research papers, and it can better provide more ..."  [Read more]
"It is very interesting to summarize the data in the work and publish scientific research papers, and it can better provide more sufficient literature support for clinical work. Thank you very much for your opinions on the article. Through continuous revision of the article, the literature is more perfect.World Stem Cell Journal is a very professional journal and is very serious about the review of papers. I believe that I can publish more important and influential articles in the future. "  [Collapse]
Li XG, Wang RM, Chen W, Yao T, Chen F, Xu YF, Lang T. Recombinant human thrombopoietin safety and efficacy in pediatric allogeneic hematopoietic stem cell transplantation: A cohort study. World J Stem Cells 2025; 17(7): 106579
2
"I am very happy with this magazine. The review opinions given by the peer review are very important, which has been very helpful to ..."  [Read more]
"I am very happy with this magazine. The review opinions given by the peer review are very important, which has been very helpful to the improvement of my paper, and at the same time, the editors of the magazine are also very friendly to me and have given me great help in the publication of my paper. "  [Collapse]
Lei XY, Chen LH, Qian LQ, Lu XD. Psychological interventions for post-stroke anxiety and depression: Current approaches and future perspectives. World J Psychiatry 2025; 15(6): 103270
3
"Dear. Editors and reviewers, I am honored to have our manuscript published in a prestigious journal. I would like to thank the editors ..."  [Read more]
"Dear. Editors and reviewers, I am honored to have our manuscript published in a prestigious journal. I would like to thank the editors and reviewers of this journal for their hard work. The editor conducted the review process quickly and fairly. The reviewers' comments helped improve the quality of the manuscript. I hope to publish manuscripts in this journal in the future. Regards, "  [Collapse]
Okpete UE, Byeon H. Optimizing perimenopausal mental health by integrating precision biomarkers, digital health interventions, and psychosocial care. World J Psychiatry 2025; 15(7): 101906
4
"I would like to thank the editors and reviewers of this journal for their hard work. The editor conducted the review process quickly ..."  [Read more]
"I would like to thank the editors and reviewers of this journal for their hard work. The editor conducted the review process quickly and fairly. The reviewers' comments helped improve the quality of the manuscript. I hope to publish manuscripts in this journal in the future. I am honored to have our manuscript published in a prestigious journal. Regards, "  [Collapse]
Okpete UE, Byeon H. Limitations of glycated hemoglobin and emerging biomarkers for diabetes care after bariatric surgery. World J Diabetes 2025; 16(7): 107928
5
"I sincerely thank the editorial team and reviewers for their thorough and constructive feedback throughout the review process. Their ..."  [Read more]
"I sincerely thank the editorial team and reviewers for their thorough and constructive feedback throughout the review process. Their valuable insights helped me refine the manuscript, enhancing its clarity and scientific rigor. It was a rewarding experience to contribute to this journal, and I appreciate the professional support provided at every stage. "  [Collapse]
Ikram E, Shaukat A, Qureshi MS, Saifullah M, Aslam MA, Mehdi AM. Monkeypox in neonates: A narrative review on clinical presentations, vertical transmission, and treatment challenges. World J Clin Infect Dis 2025; 14(1): 109806
6
"Hepatocellular carcinoma (HCC) faces critical challenges in treatment due to its complex molecular drivers and inherent ..."  [Read more]
"Hepatocellular carcinoma (HCC) faces critical challenges in treatment due to its complex molecular drivers and inherent chemoresistance. Our study addresses the significant under-investigation of Rac family small GTPase 3 (RAC3) in HCC. Integrating multiomics analyses (TCGA, GEO, GTEx) and functional genomics (CRISPR screening), we establish RAC3 as a crucial oncogenic driver. Key findings demonstrate significant RAC3 mRNA and protein overexpression in HCC tissues (validated in 108 paired samples), strongly correlating with advanced tumor stage, patient age, and reduced overall survival (HR=1.82, 95%CI:1.31-2.53). CRISPR ablation across 16 diverse HCC cell lines unequivocally proved RAC3's essential role in sustaining proliferation. Mechanistically, we uncovered a novel feedforward loop: pathway analysis revealed RAC3's core involvement in cell-cycle dysregulation, while ChIP-seq validation identified transcription factor E2F1 as the pivotal upstream regulator, directly binding the RAC3 promoter to drive its overexpression. This RAC3/E2F1 axis represents a key vulnerability. In short: RAC3 is more than "just another GTPase" – it is a linchpin of HCC progression, resistance, and poor survival. Targeting its synergy with E2F1 opens new avenues for precision therapy. "  [Collapse]
Liu R, Li JC, Li SD, Li JD, He RQ, Chen G, Feng ZB, Wei JL. Deciphering the oncogenic role of Rac family small GTPase 3 in hepatocellular carcinoma through multiomics integration. World J Hepatol 2025; 17(7): 106151
7
"Enjoyed the peer review process, which was efficient and effective. I think the submission system is user friendly, allow for rapid ..."  [Read more]
"Enjoyed the peer review process, which was efficient and effective. I think the submission system is user friendly, allow for rapid communication between the journal and authors. Additionally enjoyed the clear and concise peer review report. Would do this all over again, if given another chance. Congratulations to the F6 publishing systems. Keep up the good work. Kevan English, MD Internal Medicine University of Nebraska Medical Center "  [Collapse]
English K, Pick N, Schmitz A. Acute purulent pericarditis secondary to community-acquired streptococcus pneumonia: A case report. World J Clin Cases 2025; 13(26): 107748
8
"The journal’s submission/editing/proofreading process feels unnecessarily high-maintenance for authors. While we understand the need ..."  [Read more]
"The journal’s submission/editing/proofreading process feels unnecessarily high-maintenance for authors. While we understand the need for thoroughness, some of the required steps seem excessive and could potentially discourage submissions. It might be beneficial to evaluate whether certain parts of the process can be streamlined or removed to improve efficiency and author experience. "  [Collapse]
Wang H, Schmieder A, Watkins M, Wang P, Mitchell J, Qamer SZ, Lanza G. Artificial intelligence-assisted compressed sensing CINE enhances the workflow of cardiac magnetic resonance in challenging patients. World J Cardiol 2025; 17(7): 108745
9
"I would like to thank the editors for their support. From the beginning, they were clear, friendly, and communication was very prompt. ..."  [Read more]
"I would like to thank the editors for their support. From the beginning, they were clear, friendly, and communication was very prompt. The work of the peer reviewers was valuable and carried out with scientific rigor, which helped improve the quality of our manuscript. The publication experience has been pleasant and friendly, marked by professionalism and strong support. We are truly grateful. "  [Collapse]
Tornel Avelar AI, Gerrard CN, Priego Parra BA. Phospholipase D2: A biomarker implicated in various pancreatic diseases beyond acute pancreatitis. World J Gastroenterol 2025; 31(28): 108271
10
"I would like to thank the entire editorial team at Baishideng. Communication was clear and prompt from the beginning, and the comments ..."  [Read more]
"I would like to thank the entire editorial team at Baishideng. Communication was clear and prompt from the beginning, and the comments provided by the peer reviewers had a significant impact in improving the quality of the manuscript. The publication experience has been friendly, pleasant, and marked by strong scientific rigor. I highly recommend this journal to fellow researchers. Warm regards. "  [Collapse]
Priego-Parra BA, Román-Calleja BM, Gallego-Duran R, Gracia-Sancho J, Velarde Ruiz-Velasco JA, Remes-Troche JM. Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; 17(7): 107668
11
"To ensure the integrity and standardization of the journal content, it is recommended to use unmodifiable file formats such as PDF, ..."  [Read more]
"To ensure the integrity and standardization of the journal content, it is recommended to use unmodifiable file formats such as PDF, TIFF or JPEG when uploading images. These formats can better maintain the clarity and original quality of the images, which is beneficial for later layout and printing. Meanwhile, it is not advisable to upload images in PPT format because PPT is an editable presentation format whose image resolution often fails to meet the professional requirements of journal publication. Moreover, when opened on different devices or software, PPT files may experience format disorder, which could affect the efficiency of review or publication. Therefore, to enhance the overall quality and professionalism of the journal, authors are advised to choose appropriate file formats when submitting images to ensure the best presentation of the content. "  [Collapse]
Wang Y, Yang XN, Ji S, Zhang YM, Wang Y, Wang YM, Gu YX. Compound lidocaine cream with warm compress for pain relief in ultrasound-guided peripherally inserted central catheter placement for cancer patients. World J Clin Oncol 2025; 16(7): 108173
12
"The online submission and peer review system of the journal is good. The peer reviewed report helped us a lot to improve the quality ..."  [Read more]
"The online submission and peer review system of the journal is good. The peer reviewed report helped us a lot to improve the quality of the manuscript. We are also very much satisfied with the prepared tables and figures. We are happy with the period of publication, rules and norms. We are very much satisfied with the overall publication process. "  [Collapse]
Giri S, Mukhuty A, Mondal SA, Sahoo J, Roy A, Kamalanathan S, Naik D. Link between type 2 diabetes mellitus and hepatocellular carcinoma. World J Hepatol 2025; 17(7): 107675
13
"We sincerely appreciate the professional and efficient editorial process provided by the World Journal of Hepatology. The submission ..."  [Read more]
"We sincerely appreciate the professional and efficient editorial process provided by the World Journal of Hepatology. The submission system was user-friendly, and the peer review was timely, constructive, and insightful. The reviewers’ comments significantly improved the clarity and quality of our manuscript. The editorial office maintained excellent communication throughout the process, and the final layout of the article—including figures and tables—was of high quality. We also appreciate the journal’s emphasis on academic norms and transparency in its peer review and publishing practices. One minor suggestion is to consider further optimizing the formatting of the online full-text version on mobile devices for better readability. Nevertheless, we are overall very satisfied with the experience and would be happy to submit future work to the World Journal of Hepatology. "  [Collapse]
Li J, Wang W. Challenges of Klebsiella pneumoniae infections post-liver transplantation: Insights and future directions. World J Hepatol 2025; 17(7): 107213
14
"Thank you very much for your help with our paper. peer-reviewing and editorial work were all at the highest levels. We are satisfied ..."  [Read more]
"Thank you very much for your help with our paper. peer-reviewing and editorial work were all at the highest levels. We are satisfied with the timing and communications. the time between the acceptance and publication day is a bit long, but reasonable. All communication letters were sent to all authors, which is really good considering the involvement of all authors. Preprints could be introduced by this journal, but not essential. "  [Collapse]
Sukocheva O, Ow TW, Harding D, Le Mire M, Tse E. Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives. World J Hepatol 2025; 17(7): 106675
15
"The peer review process was exemplary—timely, transparent, and constructively rigorous. Reviewers provided detailed, actionable ..."  [Read more]
"The peer review process was exemplary—timely, transparent, and constructively rigorous. Reviewers provided detailed, actionable feedback that strengthened the manuscript substantively. Editorial coordination was efficient, communicative, and fair, with clear guidance at every stage. Overall, journal processing was excellent and thorough, reflecting high standards and a strong commitment to scholarly quality. "  [Collapse]
Duggal S, Kalra I, Kalra K, Bhagat V. Advancing hemostasis: A meta-analysis of novel vs conventional endoscopic therapies for non variceal upper gastrointestinal bleeding. World J Gastrointest Endosc 2025; 17(6): 107142
16
"The peer review process was exemplary—timely, transparent, and constructively rigorous. Reviewers provided detailed, actionable ..."  [Read more]
"The peer review process was exemplary—timely, transparent, and constructively rigorous. Reviewers provided detailed, actionable feedback that strengthened the manuscript substantively. Editorial coordination was efficient, communicative, and fair, with clear guidance at every stage. Overall, journal processing was excellent and thorough, reflecting high standards and a strong commitment to scholarly quality. "  [Collapse]
Duggal S, Kattamuri L, Sairam S. Three-year outcomes of tumor necrosis factor alpha inhibitor therapy in rheumatoid arthritis patients with elevated liver enzymes. World J Hepatol 2025; 17(7): 108051
17
"We would like to express our sincere appreciation to the publisher for the professional handling of our manuscript. We are grateful ..."  [Read more]
"We would like to express our sincere appreciation to the publisher for the professional handling of our manuscript. We are grateful for the clear communication, timely responses, and constructive feedback provided throughout the review and editing process. Your support has been essential in improving the quality and presentation of our work. "  [Collapse]
Naully PG, Tan MI, El Khobar KE, Sukowati CHC, Giri-Rachman EA. Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics. World J Hepatol 2025; 17(7): 107620
18
"I have no additional comments at this time. Thank you for your thorough review and the effort invested in the publication process. ..."  [Read more]
"I have no additional comments at this time. Thank you for your thorough review and the effort invested in the publication process. The peer review report provided valuable insights and constructive suggestions, which significantly enhanced the quality of my manuscript. It helped make my report more solid, coherent, and scientifically sound. "  [Collapse]
Hsu CW, Hsueh C, Lu YL, Hsu CJ, Wong RJ, Lin SF. Risk factors and outcomes of metastatic poorly differentiated thyroid carcinoma. World J Clin Cases 2025; 13(25): 105204
19
"It was good experience regarding publication of our invited review on Early detection of Gall bladder cnacer. Starting from submission ..."  [Read more]
"It was good experience regarding publication of our invited review on Early detection of Gall bladder cnacer. Starting from submission to publication , it was very well communicated timley at each and every step. Revew process was quick and the cooments were worth to refine the quality of manuscripts. Editorial comments and publication process was smooth and worth appreciating. "  [Collapse]
Sarangi Y, Kumar A. Early detection of gallbladder cancer: Current status and future perspectives. World J Clin Oncol 2025; 16(7): 107781
20
"The journal has demonstrated a high level of professionalism and efficiency in all aspects of manuscript processing. The online ..."  [Read more]
"The journal has demonstrated a high level of professionalism and efficiency in all aspects of manuscript processing. The online submission system is user-friendly and streamlined, greatly simplifying the submission process. The peer review reports are not only provided in a timely manner but also offer pertinent and constructive comments, which have been highly helpful in improving the quality of the manuscript. The entire review process is fair and objective. The work quality of the editorial team is commendable. The editing of the article is meticulous and rigorous, and the final PDF version and online full-text are formatted standardly with clear layout. The handling of figures and tables in the online full-text is also very standardized, accurately conveying the research content. The publication process is standardized and orderly, and the time from submission to publication is reasonable and meets expectations. In addition, the journal has done an excellent job in publicizing academic norms and requirements as well as in detecting academic misconduct, enabling authors to clearly understand various rules and reflecting the journal's emphasis on academic integrity. Overall, it has been a very pleasant submission experience, and the professionalism and standardization of this journal are trustworthy. "  [Collapse]
Zhang FM, Ning LG, Wang XX, Du HJ, Zhu HT, Chen HT. Comparison of endoscopic ultrasonography features and pathological staging of gastric inflammatory fibroid polyps. World J Gastrointest Surg 2025; 17(7): 105136
19167 items  Read more >>
Article Quality Tracking-Peer-Review
1
"The need for the development of non-invasive tests in chronic hepatitis of either etiology is necessary. The power and limitations ..."  [Read more]
"The need for the development of non-invasive tests in chronic hepatitis of either etiology is necessary. The power and limitations of the study conducted by Peta et al. are discussed well in this letter. To reach the targets of individualized medicine in AIH, the patient's multi omics data should be integrated in the upcoming assessment models. "  [Collapse]
Jerez Diaz D, Twohig P. Toward non-invasive assessment strategies in autoimmune hepatitis. World J Hepatol 2025; 17(7): 107881
2
"This is an interesting case report. Autoimmune diseases might be seen in CLL. Although the patient has no risk factor for viral ..."  [Read more]
"This is an interesting case report. Autoimmune diseases might be seen in CLL. Although the patient has no risk factor for viral hepatitis, I check the viral load in such a case. Diagnosing the viral hepatitis by measuring the antibody levels could be misleading in CLL. Moreover, there is no data regarding the serum HBc antibody level in this case. Biochemical response include the normalization of gamma globulin level and serum IgG levels (No data was provided in this report). I would be glad if there was long term follow up data including the histologic response."  [Collapse]
Giacomelli M, Carotti S, Vozella F, Pagliei F, Taffon C, Baiocchini A, Gambaro FL, Picardi A, Vespasiani-Gentilucci U, Galati G. Autoimmune hepatitis with syncytial giant cells in chronic lymphocytic leukemia: A case report and literature review. World J Hepatol 2025; 17(7): 106253
3
"In this editorial manuscript, the authors summarize both established and experimental endoscopic approaches aimed at improving ..."  [Read more]
"In this editorial manuscript, the authors summarize both established and experimental endoscopic approaches aimed at improving metabolic states in metabolic dysfunction-associated fatty liver disease. These approaches target pathways such as the gut-islet axis, gut-brain axis, intestinal microbiota and its metabolites, as well as mechanisms involving nutrient restriction and malabsorption. The procedures are concisely described, with particular emphasis on a key study involving duodenal mucosal ablation using electroporation. In addition to discussing the efficacy of each method, the authors' presentation of limitations and future directions is informative and valuable. "  [Collapse]
Fernandez CJ, Jena S, Lakshmi V, Pappachan JM. Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2025; 31(28): 109468
4
"Indeed, with liver cirrhosis, both morphofunctional restructuring of the hepatic vasculature and complex splanchnic and systemic ..."  [Read more]
"Indeed, with liver cirrhosis, both morphofunctional restructuring of the hepatic vasculature and complex splanchnic and systemic hemodynamic disturbance occur, contributing to the development of severe complications. In children, due to the rarity of liver cirrhosis, these disorders are rare, and therefore, the number of publications is small. I read with interest the article by Tambucci et al. The authors presented a well-structured review based on the current understanding of this pressing issue."  [Collapse]
Tambucci R, Stephenne X, Channaoui A, de Magnée C. Liver and systemic hemodynamics in cirrhotic children. World J Hepatol 2025; 17(7): 103179
5
"Fecal transplants have been reported to improve the intestinal flora and improve UC and Crohn’s disease. In recent years, it has been ..."  [Read more]
"Fecal transplants have been reported to improve the intestinal flora and improve UC and Crohn’s disease. In recent years, it has been reported that improving the intestinal flora improves liver damage. This is very interesting data, and it is believed that improving the intestinal flora improves bile acids and liver function. Please explain the mechanism behind this."  [Collapse]
Ma L, Zhang MH, Xu YF, Hao YX, Niu XX, Li Y, Xing HC. Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease. World J Gastroenterol 2025; 31(28): 105089
6
"The article “Stem cell therapy for diabetes: Advances, prospects, and challenges” provides a concise and informative overview of ..."  [Read more]
"The article “Stem cell therapy for diabetes: Advances, prospects, and challenges” provides a concise and informative overview of current developments in stem cell–based approaches to treating diabetes, with a particular focus on induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and pancreatic islet transplantation. Zuo et al. present the current state of research, acknowledging both the exciting advancements and the persistent challenges. However, in some cases, the discussion leans toward emphasizing successful studies and positive trial outcomes, occasionally lacking a rigorous critique of failures or contradictory findings in the field. Thus, many of the cited studies report favorable outcomes, with limited discussion of trials that yielded null results or failed to translate to clinical efficacy. Authors clearly explain the underlying biological mechanisms, such as β-cell differentiation and paracrine immunomodulation by MSCs. Noteworthy advances are documented, including CRISPR-mediated immune evasion strategies, the development of encapsulation technologies to protect transplanted cells from host immunity, and the application of bioprinting to improve islet viability and function. The authors effectively describe the transition from basic research to clinical application, citing the first-in-human trials and the survival of stem cell–derived islets for over one year in patients. These contributions add clarity and momentum to the translational landscape of regenerative diabetes therapies. Authors also acknowledges unresolved issues that remain major barriers to clinical translation. These include the risks of tumorigenicity associated with iPSCs, the low engraftment efficiency of transplanted cells, and ongoing challenges with host immune rejection. Furthermore, the absence of long-term safety and efficacy data from randomized controlled trials highlights the need for more rigorous evidence before widespread adoption. The authors propose future directions such as 3D bioprinting of organoids, AI-guided combination therapies, and further refinement of genome editing techniques to enhance safety and immune compatibility. In conclusion, this review offers a well-informed and timely synthesis of the rapidly evolving field of stem cell therapy for diabetes. It successfully highlights promising technologies and recent clinical breakthroughs while acknowledging the complexity of translating laboratory innovations into durable, safe, and accessible therapies. Future iterations of this work would benefit from deeper critical analysis of contradictory evidence, expanded discussion on regulatory and ethical frameworks, and integration of emerging clinical trial data. Such enhancements would further strengthen its contribution to the scientific community and aid in shaping the direction of next-stage research and therapeutic development."  [Collapse]
Zuo DB, Wang CH, Sang M, Sun XD, Chen GP, Ji KK. Stem cell therapy for diabetes: Advances, prospects, and challenges. World J Diabetes 2025; 16(7): 107344
7
"There is an Ethical problems, because hepatic hemangioma is benign tumor and it does not require any treatment. Transcatheter arterial ..."  [Read more]
"There is an Ethical problems, because hepatic hemangioma is benign tumor and it does not require any treatment. Transcatheter arterial chemoembolization (TACE) and microwave ablation (MWA) have an adverse events, and so authors should make clear the definition of hepatic hemangioma which needs treatment. Authors only described the prognosis after 12 months. Authors should report the longer prognosis. "  [Collapse]
Sun JP, Zhou K, Pan J, Yang N, Sun XN, Zhao HT, Yang XB. Efficacy and safety of transcatheter arterial chemoembolization combined with microwave ablation for hepatic hemangiomas (> 5 cm). World J Gastroenterol 2025; 31(28): 109078
8
"Well written manuscript, providing a detailed overview of MPox in neonates, including clinical presentation and particularities in ..."  [Read more]
"Well written manuscript, providing a detailed overview of MPox in neonates, including clinical presentation and particularities in this age group, diagnosis, treatment options and therapeutic considerations, public health challenges and future implications. Specific mention of differential diagnostic consideration is also appreciated. Reference list is relevant and complete and the quality of language is good. Although I understand that MPox is rare in children, I'd suggest if possible to add some statements on the current epidemiology of MPox in this age group, or if it is only limited to case reports. "  [Collapse]
Ikram E, Shaukat A, Qureshi MS, Saifullah M, Aslam MA, Mehdi AM. Monkeypox in neonates: A narrative review on clinical presentations, vertical transmission, and treatment challenges. World J Clin Infect Dis 2025; 14(1): 109806
9
"Vonoprazan (VPZ) is a new potassium antagonist that inhibits gastric acid secretion by blocking the binding of H+/K+-ATPase to K+ ..."  [Read more]
"Vonoprazan (VPZ) is a new potassium antagonist that inhibits gastric acid secretion by blocking the binding of H+/K+-ATPase to K+ and preventing the entry of H+ into the gastric lumen. Existing studies demonstrate that VPZ-based treatment regimens, including triple therapy regimens with VPZ, amoxicillin, and clarithromycin, are both safe and effective in eradicating H. pylori. The multicenter randomized controlled trial discussed here was the first to compare triple therapy based on VPZ (VPZ/amoxicillin/clarithromycin) with the 14-day quadruple regimen based on bismuth in China. The results showed that triple therapy with VPZ achieved higher eradication rates compared to the quadruple regimen and with similar rates of side effects, making triple therapy with VPZ an important alternative (without bismuth) for eradicating H. pylori. Interestingly, no significant differences in eradication rates were observed between the 10- and 14-day treatments. However, to optimize results and reduce the incidence of antibiotic resistance, it is necessary to conduct extensive, multicenter studies in various countries worldwide."  [Collapse]
Han RS, Hao JW, Wang T, Xin Z, Fan GX, Wang GD, Liu MM, Liu CX, Yang QZ, Yang ZW, Lv XY, Zhang C, Bian G, Meng J, Cui ZQ, Yun XJ, Cao JH, Li SH, Fan JF, Ma HG, Gao FY, Mao T, Tian ZB, Song XH, Yu YN. Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial. World J Gastroenterol 2025; 31(28): 109001
10
"The minireview "Key players in the breast cancer microenvironment: From fibroblasts to immune cells" by Sacide et al summarizes the ..."  [Read more]
"The minireview "Key players in the breast cancer microenvironment: From fibroblasts to immune cells" by Sacide et al summarizes the role of tumor microenvironment in the immune invasion, therapy resistance and metastasis process in Breast cancer. This understanding will definitely help us to explore the breast cancer progression with new therapeutic approach. The minireview is well written and beautifully presented. The language and grammar is appropriate. The referencing is good. However, a description on role of tumor microenvironment on angiogenesis and angiogenic signaling could have been discussed. Overall The review is good and useful for the scientific community."  [Collapse]
Çakal S, Er Urgancı B, ÅžimÅŸek S. Key players in the breast cancer microenvironment: From fibroblasts to immune cells. World J Clin Oncol 2025; 16(7): 107339
11
"This study concerns a consensus reached by a group of experts from the Middle East, who, with the assistance of an internationally ..."  [Read more]
"This study concerns a consensus reached by a group of experts from the Middle East, who, with the assistance of an internationally recognized German expert, formulated comprehensive guidelines on the treatment of Helicobacter pylori infection in the Middle East. It is well known that the prevalence of Helicobacter pylori infection in these countries is quite high in both adults and children. The development of antibiotic resistance in these countries is another obstacle to the effectiveness of treatment. In this sense, the formulation of these guidelines for treating Helicobacter pylori infection is useful and of practical importance, particularly about the risk of developing gastric cancer. Such activities should also be carried out in other parts of the world (e.g., Africa, Asia)."  [Collapse]
Sharara AI, Alsohaibani FI, Alsaegh A, Al Ejji K, Al Awadhi S, Malfertheiner P, Karam SA, Al-Taweel T. First regional consensus on the management of Helicobacter pylori infection in the Middle East. World J Gastroenterol 2025; 31(27): 107138
12
"This is very interesting paper about heart failure after TIPS.Heart failure can be a complication after a transjugular intrahepatic ..."  [Read more]
"This is very interesting paper about heart failure after TIPS.Heart failure can be a complication after a transjugular intrahepatic portosystemic shunt (TIPS) procedure, particularly in patients with pre-existing heart conditions or those with cirrhotic cardiomyopathy. While post-TIPS heart failure is relatively uncommon, it is crucial to understand the factors that can contribute to its development and to monitor patients closely for signs and symptoms. The author's fig4 EKG, BNP, and echocardiographic evaluations are simple and easy to understand."  [Collapse]
Tomassoni DR, Schildkraut T, Ramachandran V, Cooke JC, Sawhney R. Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. World J Gastroenterol 2025; 31(27): 107740
13
"Kwon et al. reported that deep learning-based localization and lesion detection in capsule endoscopy for patients with suspected ..."  [Read more]
"Kwon et al. reported that deep learning-based localization and lesion detection in capsule endoscopy for patients with suspected small-bowel bleeding. It maybe true the AI-based localization and lesion detection is very useful for the discovery of small-bowel bleeding in patients. If possible, authors should distribute these application for everyone examine their figures. If so, everyone could recognize the results of authors."  [Collapse]
Kwon YS, Park TY, Kim SE, Park Y, Lee JG, Lee SP, Kim KO, Jang HJ, Yang YJ, Cho BJ. Deep learning-based localization and lesion detection in capsule endoscopy for patients with suspected small-bowel bleeding. World J Gastroenterol 2025; 31(27): 106819
14
"Excellently presented study. All points are very well taken. The article provides a comprehensive perspective on all contemporary ..."  [Read more]
"Excellently presented study. All points are very well taken. The article provides a comprehensive perspective on all contemporary aspects of variceal hemorrhage management. The article is written so that it is recommended for gastroenterologists, general surgeons, hospitalists, and emergency medicine physicians. The Authors' effort constitutes a major contribution towards updating the current knowledge and understanding of the problem, and provides a foundation for database perfection. "  [Collapse]
Kogilathota Jagirdhar GS, Okafor CC, Hussain M, Elmati PR, Ghumman A, Shah M, Surani S. Decline of the Sengstaken-Blakemore tube: A review of shifting practices in gastrointestinal hemorrhage management. World J Crit Care Med 2025; 14(3): 101856
15
"Only three articles examined are very few, the search should be expanded. also missing the PROSPERO membership number and the PRISMA ..."  [Read more]
"Only three articles examined are very few, the search should be expanded. also missing the PROSPERO membership number and the PRISMA check-list. More detailed information on research should be provided to make it more rigorous. It would also be useful to specify the limitations of the study and what can be done in future studies to improve these limits Finally , a English editing is needed."  [Collapse]
Yousif Mohamed AM, Salih M, Mohamed M, Abbas AE, Elsiddig M, Osama Omar M, Abdelsalam M, Elhag B, Mohamed N, Eisa Ahmed SH, Ahmed S, Mohamed D, Omar D. Comparative efficacy of cementless bipolar hemiarthroplasty and proximal femoral nail anti-rotation in unstable intertrochanteric fractures: A meta-analysis. World J Orthop 2025; 16(7): 107950
16
"Survival rates following radical surgery for gastric neuroendocrine neoplasms (g-NENs) are low, with high recurrence rates. Liu, et ..."  [Read more]
"Survival rates following radical surgery for gastric neuroendocrine neoplasms (g-NENs) are low, with high recurrence rates. Liu, et al’s study addressed a critical issue in determining the postoperative prognosis of gastric neuroendocrine tumors by identifying the significance of lymph node ratio. Moreover, the random survival forest model, a machine-learning approach, surpasses traditional Cox proportional hazards models by enhancing predictive accuracy, clinical utility, and overall performance. This model’s ability to stratify patient risks and personalize survival predictions can aid in formulating targeted postoperative strategies, thus realizing an important aspect of personalized “precision medicine”. This paper is indicative for journal readers in this field."  [Collapse]
Wang HN, An JH, Zong L. Estimating prognosis of gastric neuroendocrine neoplasms using machine learning: A step towards precision medicine. World J Gastrointest Oncol 2024; 16(12): 4548-4552
17
"Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths due to late diagnosis and high recurrence rates. ..."  [Read more]
"Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths due to late diagnosis and high recurrence rates. Key biomarkers such as enhancer of zeste homolog 2 and fatty acid binding protein 5, along with other genetic biomarkers provide insights into HCC progression and potential therapeutic targets. This paper is indicative for journal readers in this field. "  [Collapse]
Shodry S, Hasan YTN, Ahdi IR, Ulhaq ZS. Gene targets with therapeutic potential in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(12): 4543-4547
18
"In this Editorial we comment on the interesting article by Liu, et al. The controlling nutritional status (CONUT) score was ..."  [Read more]
"In this Editorial we comment on the interesting article by Liu, et al. The controlling nutritional status (CONUT) score was significantly associated with the prognosis of colorectal cancer patients, as supported by a large body of literature. Compared with other nutritional scores, the CONUT score might be introduced in clinical practice as an optimal prognostic nutritional index to predict patient outcome."  [Collapse]
Berardi R, Chiariotti R, Mentrasti G. Is nutritional status a new indicator to use in clinical practice for colorectal cancer patients? World J Gastrointest Oncol 2024; 16(12): 4537-4542
19
"In this Editorial, they highlighted potential pitfalls in the current classification of mixed neuroendocrine non-neuroendocrine ..."  [Read more]
"In this Editorial, they highlighted potential pitfalls in the current classification of mixed neuroendocrine non-neuroendocrine neoplasms and commented on challenges in the management of this heterogeneous group of malignancies in light of the paucity of evidence in the field. Improved biological and clinical knowledge were needed to generate robust classification schemes that will in turn provide clarity on the epidemiology of the disease, prognosis of affected patients and guidance for treatment tailoring. This paper is indicative for journal readers in this field."  [Collapse]
Cives M, Porta C, Palmirotta R. Mixed neuroendocrine non-neuroendocrine tumors: The quest for evidence. World J Gastrointest Oncol 2024; 16(12): 4532-4536
20
"Gastric cancer remains a formidable global health concern with significant morbidity and mortality rates, despite the fact that ..."  [Read more]
"Gastric cancer remains a formidable global health concern with significant morbidity and mortality rates, despite the fact that numerous advances have been made to improve conventional therapies. This Editorial article integrated network pharmacology insights with rigorous experimental validation to highlight the potential of Xiaojianzhong decoction as a multifaceted therapeutic approach for gastric cancer. This paper is indicative for journal readers in this field."  [Collapse]
Cheng CH, Hao WR, Cheng TH. Exploring Xiaojianzhong decoction's potential in gastric cancer treatment: Integrative insights and experimental validation. World J Gastrointest Oncol 2024; 16(12): 4553-4558
15701 items  Read more >>
Peer-Reviewers and Manuscript Statistics
Editorial board members
2265
Peer-reviewers
32655
Manuscripts received today
5
Manuscript reviews today
23
Unhandled manuscripts today
126
Active peer-reviewers today
1118
Reviewer acceptance today
22
Reviewer refusals today
23
Total accepted manuscripts
37027
Total rejected manuscripts
42500
Total peer-reviewers
4305338
Total submissions
35221
Baishideng Publishing Group (BPG) publishes 47 peer-reviewed, open-access journals covering a broad range of topics in clinical medicine, as well as several topics in biochemistry and molecular biology, relevant to human health today.
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Sign In
  • BPG Management System
  • F6Publishing-Submit a Manuscript
  • F6Publishing-世界华人消化杂志在线投稿
  • RCA Management System
English
  • English
  • 简体中文
BPG Journals
Reference Citation Analysis
  • Find an Article (56833074)
  • Find an Article PDF (5259526)
  • Today's Articles (1296)
  • Find a Category (125)
  • Find a Journal (7896)
  • Find a Scholar (4160)
  • Find an Academic Assistant (52)
  • Subscribe (53423)
BPG E-Books
BPG Blog
All Journal Articles
1

Parchwani D, Singh R, Patel D. Biological and translational attributes of mitochondrial DNA copy number: Laboratory perspective to clinical relevance. World J Methodol 2025; 15(3): 102709

2025-09-20 | Browse: 5292 | Download: 853
2

Tawheed A, Ismail A, El-Tawansy A, Maurice K, Ali A, El-Fouly A, Madkour A. Third space endoscopy pulmonary complications and chylothorax post peroral endoscopic myotomy. World J Methodol 2025; 15(3): 102703

2025-09-20 | Browse: 5046 | Download: 833
3

Bajpai J, Saxena M, Pradhan A, Kant S. Sotatercept: A novel therapeutic approach for pulmonary arterial hypertension through transforming growth factor-β signaling modulation. World J Methodol 2025; 15(3): 102688

2025-09-20 | Browse: 6182 | Download: 802
4

Bale BI, Zeppieri M, Idogen OS, Okechukwu CI, Ojo OE, Femi DA, Lawal AA, Adedeji SJ, Manikavasagar P, Akingbola A, Aborode AT, Musa M. Seeing the unseen: The low treatment rate of eye emergency in Africa. World J Methodol 2025; 15(3): 102477

2025-09-20 | Browse: 5985 | Download: 908
5

Vo LT, Vu T, Pham TN, Trinh TH, Nguyen TT. Machine learning-based models for prediction of in-hospital mortality in patients with dengue shock syndrome. World J Methodol 2025; 15(3): 101837

2025-09-20 | Browse: 5423 | Download: 1167
6

Chauhan R, Padiyar N, Kaurani P, Gupta A, Chauhan S. Comparative evaluation of retentive capacity of three different attachment systems for implant retained overdentures: An in vitro study. World J Methodol 2025; 15(3): 101057

2025-09-20 | Browse: 5582 | Download: 1005
7

Shah P, Shah VM, Saravanan VR, Kumar K, Narendran S. Evaluation of macular and peripapillary structure and microvasculature with optical coherence tomography angiography in migraine in Indian population. World J Methodol 2025; 15(3): 100950

2025-09-20 | Browse: 5138 | Download: 1091
8

Drăgoi AL, Nemeș RM. “Electronic Pediatrician”, a non-machine learning prototype artificial intelligence software for pediatric computer-assisted pathophysiologic diagnosis — general presentation. World J Methodol 2025; 15(3): 100903

2025-09-20 | Browse: 5193 | Download: 1069
9

Drăgoi AL, Nemeș RM. The remarkable effects of the ionized medical water Asea® in 3 boys with Duchenne dystrophy: Three case reports. World J Methodol 2025; 15(3): 100840

2025-09-20 | Browse: 6747 | Download: 969
10

Fawaz P, El Sayegh P, Vande Vannet B. Artificial intelligence in revolutionizing orthodontic practice. World J Methodol 2025; 15(3): 100598

2025-09-20 | Browse: 8623 | Download: 1019
11

Khokhar RK, Nashwan AJ. Gut virome and its emerging role in inflammatory bowel disease. World J Methodol 2025; 15(3): 100534

2025-09-20 | Browse: 3728 | Download: 781
12

English K. Echo contrast medium: How the use of contrast echocardiography (ultrasound contrast agents) can improve patient care. World J Methodol 2025; 15(3): 100490

2025-09-20 | Browse: 4825 | Download: 799
13

Tramontana A, Rulli M, Falegnami A, Bilotta F. Visual avatar to increase situational awareness in anaesthesia: Systematic review of recent evidence. World J Methodol 2025; 15(3): 100459

2025-09-20 | Browse: 5065 | Download: 850
14

Li XL, Megdadi M, Quadri HS. Interaction between gut virome and microbiota on inflammatory bowel disease. World J Methodol 2025; 15(3): 100332

2025-09-20 | Browse: 3734 | Download: 711
15

Raveendran AV. Clinical inertia in sexual medicine practice. World J Methodol 2025; 15(3): 99874

2025-09-20 | Browse: 4924 | Download: 764
16

Tarazi A, Aburrub A, Hijah M. Use of artificial intelligence in neurological disorders diagnosis: A scientometric study. World J Methodol 2025; 15(3): 99403

2025-09-20 | Browse: 6365 | Download: 984
17

Casu C, Inchingolo AM, Orrù G. Interleukin 10 supplement to reduce episodes of recurrent aphthous stomatitis. World J Methodol 2025; 15(3): 99176

2025-09-20 | Browse: 4681 | Download: 729
18

Singh K, Nashwan AJ. Innovative forecasting models for nurse demand in modern healthcare systems. World J Methodol 2025; 15(3): 99162

2025-09-20 | Browse: 4103 | Download: 724
19

Kodali R, Parasar K, Anand U, Singh BN, Kant K, Arora A, Karthikeyan V, Anwar S, Saha B, Wadaskar S. Evidence-based approach for intraabdominal drainage in pancreatic surgery: A systematic review and meta-analysis. World J Methodol 2025; 15(3): 99080

2025-09-20 | Browse: 5387 | Download: 1016
20

Al-Beltagi M. Fishing reviewing: A threat to research integrity and credibility. World J Methodol 2025; 15(3): 98795

2025-09-20 | Browse: 4464 | Download: 751
59449 items  Read more >>
Featured Articles
1

Liu R, Li JC, Li SD, Li JD, He RQ, Chen G, Feng ZB, Wei JL. Deciphering the oncogenic role of Rac family small GTPase 3 in hepatocellular carcinoma through multiomics integration. World J Hepatol 2025; 17(7): 106151

2025-07-26 | Browse: 31 | Download: 81
2

Feng YF, Zhou HK, Hu BB, Wang H, Liang HK, Wei L, Li QM, Su TM, Yin QB, Su MH, Jiang JN. Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis. World J Hepatol 2025; 17(7): 108850

2025-07-26 | Browse: 30 | Download: 82
3

Mkarem LE, Batika MAH, Bitar R. New hope in treating progressive familial intrahepatic cholestasis in children. World J Hepatol 2025; 17(7): 108253

2025-07-26 | Browse: 30 | Download: 54
4

Tambucci R, Stephenne X, Channaoui A, de Magnée C. Liver and systemic hemodynamics in cirrhotic children. World J Hepatol 2025; 17(7): 103179

2025-07-26 | Browse: 35 | Download: 68
5

Korchilava B, Khachidze T, Megrelishvili N, Svanadze L, Kakabadze M, Tsomaia K, Jintcharadze M, Kordzaia D. Liver regeneration after partial hepatectomy: Triggers and mechanisms. World J Hepatol 2025; 17(7): 107378

2025-07-26 | Browse: 34 | Download: 76
6

Steri L, Barbieri P, Gigante L, Posa A. Prophylactic occlusion balloon in placenta abnormalities: What every interventional radiologist needs to know. World J Radiol 2025; 17(7): 107737

2025-07-25 | Browse: 34 | Download: 62
7

Singh JP, Assaie-Ardakany S, Aleissa MA, Al-Shaer K, Chitragari G, Drelichman ER, Mittal VK, Bhullar JS. Optimizing diagnosis in obstructed defecation syndrome: A review of imaging modalities. World J Radiol 2025; 17(7): 107459

2025-07-25 | Browse: 33 | Download: 59
8

Amano Y, Iso K, Suzuki Y, Tachi M. Cardiac magnetic resonance imaging contributing to primary prevention and secondary prevention of sudden cardiac death: Contemporary usefulness and limitations. World J Radiol 2025; 17(7): 107140

2025-07-25 | Browse: 27 | Download: 56
9

Zhang Y, Hao J, Luo Z, Li YJ, Liu Z, Zhao NB. Detecting biliary complications following liver transplantation with contrast-enhanced ultrasound. World J Radiol 2025; 17(7): 106556

2025-07-25 | Browse: 34 | Download: 70
10

Liu QZ, Zeng L, Sun NZ. Radiomics for preoperative pancreatic ductal adenocarcinoma risk stratification: Cross-population validation, multidimensional integration, challenges, and future directions. World J Radiol 2025; 17(7): 110048

2025-07-25 | Browse: 27 | Download: 65
11

Zhou Y, Xu BT, Zhou HY, Shang ZT. Long noncoding ribonucleic acid ENST00000517482 enhances mesenchymal stem cell therapy against acute lung injury. World J Stem Cells 2025; 17(7): 109064

2025-07-24 | Browse: 49 | Download: 79
12

Kumar D, Tanwar R, Gupta V. First-ever stem cell therapy restores insulin independence in type 1 diabetes: A medical milestone. World J Stem Cells 2025; 17(7): 106856

2025-07-24 | Browse: 48 | Download: 70
13

Wang K, Lin W, Han JY, Chen JY, Liu RH, Yu Z, Jin JJ. Differentiation of patient-specific induced pluripotent stem cells derived from type 1 diabetes peripheral blood mononuclear cells into pancreatic β-like cells. World J Stem Cells 2025; 17(7): 104607

2025-07-24 | Browse: 49 | Download: 124
14

Li XG, Wang RM, Chen W, Yao T, Chen F, Xu YF, Lang T. Recombinant human thrombopoietin safety and efficacy in pediatric allogeneic hematopoietic stem cell transplantation: A cohort study. World J Stem Cells 2025; 17(7): 106579

2025-07-24 | Browse: 38 | Download: 110
15

Ma WG, Si YX, Zhang YL, Gao WF, Dong YG, Li YQ, Xu ZF, Xi Q, Li ZZ. Combining acupuncture and mesenchymal stem cell therapy offers promise as a treatment for inflammatory bowel disease. World J Stem Cells 2025; 17(7): 105371

2025-07-24 | Browse: 36 | Download: 64
16

Han RS, Hao JW, Wang T, Xin Z, Fan GX, Wang GD, Liu MM, Liu CX, Yang QZ, Yang ZW, Lv XY, Zhang C, Bian G, Meng J, Cui ZQ, Yun XJ, Cao JH, Li SH, Fan JF, Ma HG, Gao FY, Mao T, Tian ZB, Song XH, Yu YN. Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial. World J Gastroenterol 2025; 31(28): 109001

2025-07-24 | Browse: 98 | Download: 160
17

Yao MJ, Xing YF, Liu SH, Peng YF, Yang SH, Chen JJ, Zhao JM, Wang H. Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric nonalcoholic fatty liver disease. World J Gastroenterol 2025; 31(28): 108321

2025-07-24 | Browse: 66 | Download: 160
18

Sun JP, Zhou K, Pan J, Yang N, Sun XN, Zhao HT, Yang XB. Efficacy and safety of transcatheter arterial chemoembolization combined with microwave ablation for hepatic hemangiomas (> 5 cm). World J Gastroenterol 2025; 31(28): 109078

2025-07-24 | Browse: 66 | Download: 152
19

Skok K, Vihar B, Maver U, Gradišnik L, Bräutigam K, Trapecar M, Skok P. Gastrointestinal tract, its pathophysiology and in-vitro models: A “quick” reference guide to translational studies. World J Gastroenterol 2025; 31(28): 108297

2025-07-24 | Browse: 63 | Download: 107
20

Fernandez CJ, Jena S, Lakshmi V, Pappachan JM. Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2025; 31(28): 109468

2025-07-24 | Browse: 56 | Download: 76
9735 items  Read more >>
Keyword Search Published Articles Processes
1
Case report
2853
2
Case report
1690
3
Hepatocellular carcinoma
1435
4
Gastric cancer
1010
5
Colorectal cancer
988
6
Inflammatory bowel disease
717
7
COVID-19
705
8
Prognosis
670
9
Liver transplantation
620
10
Ulcerative colitis
556
11
Treatment
552
12
Helicobacter pylori
519
13
Diagnosis
517
14
Crohn’s disease
514
15
Cirrhosis
479
16
Endoscopy
479
17
Meta-analysis
454
18
Pancreatic cancer
444
19
Magnetic resonance imaging
440
20
Surgery
423
70657 items  Read more >>
Reader Comments
1
"This research highlights the potential of NET-related markers as biomarkers for liver damage, offering a promising avenue for early ..."  [Read more]
"This research highlights the potential of NET-related markers as biomarkers for liver damage, offering a promising avenue for early diagnosis and therapeutic targeting. The study is particularly relevant given the global rise in metabolic diseases and liver conditions like MASLD. The inclusion of multiple models allows for a more comprehensive understanding of how different types of liver damage—fibrosis, steatohepatitis, and simple steatosis—affect systemic inflammation and NET formation. These findings could pave the way for novel treatment strategies focusing on regulating NETosis, which may be beneficial for clinical management of MASLD and related liver diseases. "  [Collapse]
FejeÅ¡ A, Belvončíková P, Bečka E, Strečanský T, Pastorek M, Janko J, Filová B, Babál P, Å ebeková K, Borbélyová V, Gardlík R. Myeloperoxidase, extracellular DNA and neutrophil extracellular trap formation in the animal models of metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2025; 31(27): 106166
2
"This paper provides an insightful contribution to the field of MAFLD by developing a machine learning-based model for early detection ..."  [Read more]
"This paper provides an insightful contribution to the field of MAFLD by developing a machine learning-based model for early detection in high-metabolic-risk populations. The integration of clinical data and TCM features adds a unique, holistic perspective, which could enhance the model's diagnostic power. The use of advanced statistical methods, such as LASSO and RFE, strengthens the reliability of the predictive model. The XGBoost algorithm demonstrated superior performance, making it a promising tool for non-invasive MAFLD screening in clinical settings. Overall, the study presents a significant step towards improving MAFLD detection and has promising clinical implications, especially in cost-effective screening and early intervention for at-risk populations. "  [Collapse]
Tian Y, Zhou HY, Liu ML, Ruan Y, Yan ZX, Hu XH, Du J. Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk. World J Gastroenterol 2025; 31(27): 108200
3
"Tian et al. (2025) present a compelling prospective observational study employing machine learning (ML) to identify biochemical and ..."  [Read more]
"Tian et al. (2025) present a compelling prospective observational study employing machine learning (ML) to identify biochemical and clinical markers predictive of hepatic steatosis in individuals at high metabolic risk. Metabolic-associated fatty liver disease (MAFLD) is prevalent yet frequently underdiagnosed, especially in early stages when traditional screening modalities like ultrasonography lack sensitivity. Thus, the authors’ development of a noninvasive, cost-effective ML-based predictive model is timely and clinically relevant, aiming for early identification and improved resource utilization. A methodological strength of the study is its comprehensive use of multiple ML algorithms—XGBoost, Random Forest (RF), Support Vector Machine (SVM), and Logistic Regression (LR)—representing diverse modeling approaches. This allowed for robust comparative analysis, with each algorithm selected for specific strengths: XGBoost for nonlinear interactions, RF for overfitting resistance, SVM for high-dimensional data, and LR for baseline interpretability. This methodological breadth effectively balances predictive performance and clinical practicality. To manage high-dimensional data (156 initial candidate features), the study employed dual feature selection techniques: recursive feature elimination (RFE) and Least Absolute Shrinkage and Selection Operator (LASSO) regression. Combining these strategies yielded a robust set of ten core features, significantly reducing complexity while ensuring predictive accuracy. These final predictors, including the AST/ALT ratio, triglycerides, and waist circumference, are clinically meaningful and closely correlate with hepatic steatosis, reinforcing the validity of their selection. Among the ML models evaluated, XGBoost demonstrated superior performance with an area under the ROC curve (AUC) of approximately 0.82, surpassing RF, SVM, and LR. XGBoost’s predictive strength was further validated through cross-validation (mean AUC ~0.918), suggesting robust internal consistency. Importantly, the model achieved high accuracy (84%) and an F1-score of 0.84, reflecting a balanced sensitivity and specificity crucial for clinical implementation. Another innovative aspect was incorporating Traditional Chinese Medicine (TCM) indicators alongside conventional clinical metrics. Two TCM-derived features, greasy tongue coating and tongue edge redness, emerged prominently among the top predictors, bridging traditional holistic diagnostics and contemporary data analytics. These TCM indicators likely represent underlying metabolic dysregulation consistent with “damp-heat” conditions in TCM theory, aligning with inflammation and metabolic dysfunction commonly observed in MAFLD. Incorporating TCM features provides valuable additional diagnostic perspectives, potentially capturing subtle clinical signs not represented in standard biomedical metrics. The quantitative integration of these features through digital analysis and expert validation represents a significant methodological innovation. However, several practical challenges must be considered. TCM diagnostic standardization and reproducibility outside controlled research settings may pose limitations. Differences in tongue appearance influenced by diet, hydration, and oral hygiene could introduce variability. Thus, ensuring consistent reproducibility and gaining broad clinical acceptance remain critical tasks for future research. Clinically, the authors’ ML tool holds significant promise for noninvasive screening, particularly valuable in routine healthcare settings where expensive or invasive procedures like MRI-PDFF or liver biopsies are impractical. This model’s reliance on common biochemical and clinical data enhances its applicability, particularly in resource-limited settings. Stratification by predicted risk allows targeted use of advanced imaging or specialist follow-up, optimizing clinical workflows and resource allocation. Nevertheless, the model’s limitations must be acknowledged. First, external validation in multicenter cohorts is essential, given the study’s single-center design and potential population-specific biases. Moreover, the lack of MAFLD subtyping overlooks disease heterogeneity, possibly limiting predictive accuracy for specific patient subsets (e.g., diabetic vs. non-diabetic patients, mild vs. severe steatosis). Addressing these nuances through subgroup-specific analyses or longitudinal follow-up studies will enhance interpretability and clinical utility. Future research could expand the feature set to include advanced biomarkers or imaging modalities to enhance predictive precision. Further, refining TCM integration through sophisticated image analysis or correlating TCM features with biochemical markers would provide stronger mechanistic insights. Prospective studies evaluating clinical outcomes of model-driven interventions, such as lifestyle modification or TCM-based therapies, could demonstrate tangible patient benefits and validate real-world clinical impact. In conclusion, Tian et al. present a robustly designed study introducing an innovative ML-based approach for early hepatic steatosis detection in high-risk populations. The inclusion of TCM diagnostic features exemplifies a novel integration of traditional medicine within contemporary predictive frameworks. Although initial results are promising, external validation, refinement for disease heterogeneity, and practical clinical integration remain critical next steps. This pioneering work significantly contributes to metabolic medicine and predictive hepatology, paving the way for improved, patient-centered management of fatty liver disease. "  [Collapse]
Tian Y, Zhou HY, Liu ML, Ruan Y, Yan ZX, Hu XH, Du J. Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk. World J Gastroenterol 2025; 31(27): 108200
4
"This article provides forward-looking insights into liver disease treatment. It begins by accurately identifying the key factors ..."  [Read more]
"This article provides forward-looking insights into liver disease treatment. It begins by accurately identifying the key factors contributing to chronic liver diseases such as alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease, and metabolic dysfunction-associated steatohepatitis, as well as the limitations of current treatments. This lays a solid foundation for subsequent innovative treatment ideas, helping readers clearly understand the existing challenges.When exploring solutions, it skillfully combines nanoparticles, gut microbiome modulation, and artificial intelligence, showcasing the immense potential of interdisciplinary integration. It lists various key types of nanocarriers, offering researchers abundant references, and elaborates on their diverse applications in modulating the gut microbiome for the treatment of chronic liver diseases, thereby broadening research perspectives.However, there is room for improvement in the details. For instance, the listed future challenges are somewhat vague. If each challenge were supported by more specific examples or data, the article would be more convincing. Additionally, a more in-depth explanation of how artificial intelligence precisely predicts treatment responses and enables personalized interventions could be beneficial, making it easier for readers without expertise in AI to understand.Overall, this article injects new vitality and hope into the field of liver disease treatment. It offers valuable insights for researchers and medical professionals. It is believed that these innovative therapeutic approaches will soon be applied in clinical practice, thereby enhancing patients' prognoses and quality of life. The article holds significant scientific and practical importance and is worthy of further research and attention. "  [Collapse]
Khurana A, Hartmann P. Gut microbiome-specific nanoparticle-based therapeutics for liver diseases. World J Gastroenterol 2025; 31(27): 109105
5
"In this commentary, we discuss the recent work by He et al. published in the World Journal of Gastroenterology, which identifies ..."  [Read more]
"In this commentary, we discuss the recent work by He et al. published in the World Journal of Gastroenterology, which identifies translocator protein (TSPO) as a novel player in the immunopathogenesis of inflammatory bowel disease (IBD), with a particular focus on neutrophil-driven ROS production and NET formation. The study highlights elevated TSPO expression in both the gut and peripheral neutrophils of IBD patients and further correlates this with increased neuroinflammatory signals in the brains of colitic mice. We commend the authors for linking gut and brain inflammation via TSPO, a mitochondrial protein long implicated in innate immune regulation. However, we offer several points for deeper consideration. Prior studies have shown that TSPO knockout in mice worsens DSS-induced colitis by enhancing macrophage pyroptosis, suggesting that TSPO may have cell-type–dependent functions. This contrasts with He et al.'s findings that TSPO antagonism reduces neutrophil ROS and NETs, raising questions about the net effects of modulating TSPO. We propose that future studies adopt cell-specific knockout models to clarify these roles. Additionally, we address the translational relevance of TSPO imaging in the CNS. In rodents, TSPO is upregulated in activated microglia; however, human data suggest that TSPO levels correlate more with immune cell density than activation state. This distinction is crucial when interpreting PET signals in IBD-associated brain inflammation. Moreover, astrocytic TSPO expression may contribute to these findings and deserves further discussion. We also suggest validating the current results in larger human cohorts, including through single-cell RNA sequencing and TSPO-PET studies. Investigating the behavioral and cognitive consequences of colitis-induced brain TSPO changes would further elucidate the gut-brain inflammatory axis. Finally, given the contradictory effects of different TSPO ligands (e.g., PK11195 vs. flunitrazepam), a pharmacological exploration of TSPO modulators with improved selectivity and safety is warranted. In conclusion, this letter supports the innovative perspective introduced by He et al., while also emphasizing the complexity of TSPO’s role across immune cell types and organ systems. A more nuanced understanding of TSPO biology may yield novel insights into both intestinal and neuroimmune pathologies. "  [Collapse]
He Q, Wu XH, Jiang DL, Lin RT, Xie F, Guan YH, Fei AH. Translocator protein facilitates neutrophil-mediated mucosal inflammation in inflammatory bowel diseases. World J Gastroenterol 2025; 31(27): 109239
6
"This study has applied a combined method of machine learning and regression analysis to evaluate the critical biomarkers in the ..."  [Read more]
"This study has applied a combined method of machine learning and regression analysis to evaluate the critical biomarkers in the diagnosis of Metabolic-associated fatty liver disease in patients. There are many correlated factors in this subsequent calculation under authors' efforts. We have considered these results to find a phenomenon that all these correlated factors coefficient values are not high. Hope that the author can explain them with scientific viewpoint. "  [Collapse]
Tian Y, Zhou HY, Liu ML, Ruan Y, Yan ZX, Hu XH, Du J. Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk. World J Gastroenterol 2025; 31(27): 108200
7
"Crohn's disease (CD) is a chronic, relapsing inflammatory bowel disease that requires long-term treatment. Infliximab (IFX) plays ..."  [Read more]
"Crohn's disease (CD) is a chronic, relapsing inflammatory bowel disease that requires long-term treatment. Infliximab (IFX) plays an important role in inducing remission and maintaining treatment. However, the high incidence of secondary loss of response (SLOR) poses a significant challenge to disease control. Currently, clinical prediction methods for SLOR are limited, and traditional clinical indicators and imaging examinations are not precise enough for prediction. This study, through radiomics technology, integrates the features of the intestinal wall and creeping fat to develop a prediction model that may help identify high-risk patients in advance. This could facilitate earlier adjustment of treatment plans in clinical practice, prevent disease relapse or exacerbation due to SLOR, and reduce unnecessary treatment delays and waste of medical resources. In terms of research methodology, the retrospective analysis used in this study is feasible in practice and makes full use of existing clinical and imaging data. The clinical independent predictors identified through univariate and multivariate analyses, such as white blood cell count, disease duration, and Harvey-Bradshaw Index, are easily obtainable in daily clinical work and are consistent with the factors we clinically observe to be related to SLOR. This makes the study results more easily applicable in clinical practice. The extraction and analysis of radiomics features are also scientifically sound and reasonable. By considering both the intestinal wall and creeping fat, the study fully takes into account the pathological characteristics of Crohn's disease. Creeping fat, as one of the characteristic pathological changes of CD, is increasingly recognized for its role in disease progression and treatment response. Including it in the analysis provides new insights into understanding the pathophysiological mechanisms of CD. The research results are encouraging. The combined prediction model shows good predictive performance in both the training and validation cohorts, indicating high predictive accuracy. This means that the model is highly reliable in practical applications and can provide accurate SLOR risk assessments for clinicians. Through this model, patients can be divided into high-risk and low-risk subgroups to achieve individualized treatment management. For high-risk patients, we can strengthen monitoring, shorten follow-up intervals, and adjust treatment plans in a timely manner, such as increasing IFX dosage or shortening dosing intervals. For low-risk patients, the standard treatment plan can be maintained to avoid overtreatment. This individualized treatment strategy is expected to improve treatment outcomes and patient prognosis. However, the study also has some limitations. The sample size is relatively small, with only 220 patients from two centers included, which may limit the generalizability of the model. In actual clinical applications, patients from different regions and medical centers may vary, so further validation of the model's stability and accuracy is needed in larger-scale multicenter studies. In addition, the study did not include some biomarkers that may have predictive value for SLOR, such as fecal calprotectin. These biomarkers are commonly used in clinical practice to assess intestinal inflammation activity. Including them in the prediction model may further improve its predictive performance. Future studies should consider integrating more clinical indicators and biomarkers to develop a more comprehensive prediction model. Overall, this study provides new ideas and tools for the management of Crohn's disease. As a gastroenterologist, I look forward to further validation and application of this study in clinical practice. Through radiomics technology, we may be able to more accurately predict secondary loss of response to IFX, thereby providing more individualized treatment plans for patients and improving the long-term prognosis of patients with Crohn's disease. At the same time, I also hope that future studies can overcome existing limitations and further optimize the prediction model to provide stronger support for clinical treatment decisions. "  [Collapse]
Li S, Zhu C, Tong L, Zheng XM, Rong C, Gao YK, Yuan DC, Wu XW. Correlation between radiomic features of Crohn's disease and secondary loss of response to infliximab. World J Gastroenterol 2025; 31(27): 109459
8
"This study aims to address the issues of time-consuming interpretation and reliance on the experience of readers when using small ..."  [Read more]
"This study aims to address the issues of time-consuming interpretation and reliance on the experience of readers when using small bowel capsule endoscopy (SBCE) to evaluate obscure gastrointestinal bleeding (OGIB). An AI model was developed to automatically distinguish the small intestine, stomach, and colon, and diagnose small intestinal abnormalities such as erosions, ulcers, vascular malformations, and bleeding. Using 87,005 images from 101 SBCE videos as the dataset, the researchers built models based on DenseNet161 and DenseNet201 convolutional neural networks, trained them through preprocessing and data augmentation, and validated their clinical utility on 32 external videos. The results showed that the model achieved over 99% accuracy in organ localization (AUC > 0.99) and 99.4% to 99.9% accuracy in lesion detection in internal testing. The AI-assisted reading time was significantly reduced to an average of 8.7 minutes (compared to 53.9 minutes traditionally), and the diagnostic performance was comparable to traditional reading. The discussion pointed out that the model significantly improved efficiency while maintaining high accuracy, but limitations included the dataset mainly consisting of Asian patients, being limited to a specific platform (MiroCam), having a small external validation sample (32 cases), incomplete coverage of lesion types, and the lack of advanced image enhancement techniques. The conclusion is that AI-assisted SBCE reading can reduce time and maintain performance, making it suitable for clinical implementation to improve consistency and efficiency. Readers believe this can help clinicians improve work efficiency and reduce misdiagnosis. Future research should expand the sample size, cover more lesion types, adapt to different platforms, and integrate advanced technologies to optimize diagnostic capabilities. "  [Collapse]
Kwon YS, Park TY, Kim SE, Park Y, Lee JG, Lee SP, Kim KO, Jang HJ, Yang YJ, Cho BJ. Deep learning-based localization and lesion detection in capsule endoscopy for patients with suspected small-bowel bleeding. World J Gastroenterol 2025; 31(27): 106819
9
"The manuscript is well organized, written in clear language and using scientific terms. The information presented is accurate, but ..."  [Read more]
"The manuscript is well organized, written in clear language and using scientific terms. The information presented is accurate, but there are several gaps, including the very small sample size which makes the results not significant. For the medical treatment to be of an impact significance, the study should be conducted on an importantly significant sample size. Also, the factors studied are important, but a wider variety of factors should be taken into consideration to give a powerful significant for the study. Aswell, the recurrence rate of VAs after sirolimus treatment is a very crucial factor. This factor is important to determine the efficacy of the treatment and its impact on controlling the medical condition. Aswell, it is important to present the long-term adverse effects of sirolimus treatment and emphasize on gastrointestinal, cardiac, and pulmonary side effects based on its mechanism of action. In conclusion, sirolimus is an effective medically treatment of vascular anomalies, but the limitations of the study classify it as not significant due mainly to the very small sample size included. "  [Collapse]
Sun Q, Wu JC, Chen X, Li DH, Li BR, Xiao NJ, Wang XY, Tu XZ, Ning SB, Sun T. Efficacy and safety of sirolimus in the treatment of gastrointestinal angiodysplasias. World J Gastroenterol 2025; 31(25): 105677
10
"The authors gave a comprehensive review of sedation protocols, factors associated with successful cannulation, various biliary ..."  [Read more]
"The authors gave a comprehensive review of sedation protocols, factors associated with successful cannulation, various biliary cannulation techniques, accessories, potential complications related to ERCP, and endoscopic ultrasound-guided ERCP. They also gave a fantastic pictorial representation of the same. However, the authors have not included the Erlanger technique and Burdick’s technique of cannulation, which can be used in appropriate settings. One additional variation in the technique described for free-hand access sphincterotomy using a needle knife, which is employed in our institute, involves a change in direction. Specifically, rather than cephalad, if the direction is caudal from the roof, the complication rates may decrease, with an increase in the rate of cannulation. We also described this variation in this letter: https://doi.org/10.1007/s12664-025-01772-w. Overall, this review provided an exhaustive review of the available literature and techniques for improving successful biliary cannulation. "  [Collapse]
Ismail A, Abdelwahab MM, Ozercan M, Elnahas O, Bahcecioglu IH, Yalniz M, Tawheed A. Strategies for achieving successful cannulation in endoscopic retrograde cholangiopancreatography: A technical overview. World J Gastrointest Endosc 2025; 17(7): 107810
11
"To the Editor, We read with great interest the article by Ren et al. [1], published in World Journal of Gastroenterology, which ..."  [Read more]
"To the Editor, We read with great interest the article by Ren et al. [1], published in World Journal of Gastroenterology, which investigates serum exosomal hsa-let-7f-5p as a potential non-invasive biomarker for detecting metastatic pancreatic cancer. The research presents a compelling advancement in the molecular diagnostics of one of the most aggressive malignancies. This study is both timely and relevant, considering the dismal survival rates in pancreatic cancer due to delayed diagnosis and poor response to conventional therapies [1, 2]. In this letter, we aim to provide a critical appraisal of the study design and methodology, place the findings in the context of the current scientific literature, evaluate the novelty and translational potential of hsa-let-7f-5p, and recommend avenues for future research. Ren et al. successfully shown that hsa-let-7f-5p is considerably higher in the serum exosomes of patients with metastatic pancreatic cancer than in those with localized illness. They discovered 42 differently expressed miRNAs using high-throughput sequencing and verified hsa-let-7f-5p using qRT-PCR, providing strong support for their result. These findings are consistent with a growing body of data that exosomal miRNAs, due to their stability in circulation and tumor selectivity, have intriguing diagnostic capacities in malignancies [3-5]. The reason for using serum exosomal miRNAs as biomarkers is widely understood. Exosomes are small vesicles released by nearly all cells, including tumor cells, that carry molecular cargo specific to their cell of origin. Previous research has demonstrated the usage of exosomal miRNAs such as miR-21, miR-1246, and miR-10b in pancreatic cancer [6-8]. However, few studies have focused on distinguishing metastatic from non-metastatic pancreatic cancer, which is an important clinical differential. One of the major strengths of Ren et al.'s work is the comprehensive pipeline employed for exosome isolation, characterization, and miRNA profiling. The authors validated exosomes using well-established techniques such as transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blotting. This multiparametric validation boosts the credibility of their results. The let-7 family of miRNAs is known for its tumor-suppressive and context-dependent oncogenic roles. While most members inhibit proliferation and metastasis, emerging evidence shows that specific let-7 members, such as let-7f-5p, can be upregulated in certain cancers and are associated with worse outcomes [9]. Ma et al. reported that hsa-let-7f-5p was highly expressed in pulmonary carcinoid tumors and regulated HMGA2, a protein involved in chromatin remodeling and EMT [10]. In prostate cancer, Valera et al. found higher hsa-let-7f-5p expression in older patients, suggesting its possible role in tumor progression with age [11]. Ren et al.’s results extend these findings to pancreatic cancer, highlighting the utility of hsa-let-7f-5p as a stage-specific biomarker rather than merely a diagnostic one. The strength of hsa-let-7f-5p as a diagnostic marker for metastasis is promising, but a comparative evaluation with other known biomarkers would enrich the discussion. For instance: miR-21 has been extensively validated as an oncogenic miRNA in pancreatic cancer and is known to promote invasion and resistance to gemcitabine [12]. miR-155 and miR-196a have been associated with poor prognosis and have been considered for early diagnostic panels [13]. In this investigation, I discovered many weaknesses. The first is a small sample size (n=36), and the lack of longitudinal follow-up data limits the findings' generalizability and prognostic application. Multicenter trials with larger and more diverse cohorts are required to verify hsa-let-7f-5p as a clinical biomarker. Furthermore, only four miRNAs were validated, leaving the other 38 (including 34 unique ones) untested. Some of these may have even greater discriminatory strength or synergistic benefit when integrated into multi-miRNA signatures, a method that has demonstrated increased accuracy in other malignancies. Moreover, the biological activities of hsa-let-7f-5p in encouraging metastasis warrant additional investigation. Functional research using in vitro invasion tests and in vivo metastasis models could help determine whether this miRNA is simply a marker or a mechanistic component to metastatic spread. Another topic to look at is if exosomal hsa-let-7f-5p levels alter in response to treatment. If so, this could lead to real-time, non-invasive therapy monitoring, which is critical in pancreatic oncology. The authors recommend using hsa-let-7f-5p in routine surveillance to detect metastases in pancreatic cancer patients, possibly in conjunction with imaging. We support this objective and urge that commercial assay kits be developed and clinically validated in accordance with CLIA/CAP requirements. Given that the majority of pancreatic cancer patients come with late-stage disease, a non-invasive technology for early detection of metastases can have a considerable impact on treatment decisions, such as avoiding non-curative surgery or starting systemic therapy earlier. Furthermore, including such biomarkers into AI-driven diagnostic pipelines has the potential to improve risk classification algorithms and customize treatment regimens, in line with precision medicine concepts. Ren et al. provide a valuable contribution to the field by identifying serum exosomal hsa-let-7f-5p as a potential diagnostic biomarker for metastatic pancreatic cancer. The study is technically sound, analytically robust, and biologically plausible. Nevertheless, broader validation, mechanistic studies, and clinical comparisons with existing biomarkers are necessary to cement its place in clinical practice. We commend the authors for their innovative and methodologically rigorous work and look forward to seeing the next phase of this research. Their findings not only enhance our understanding of pancreatic cancer metastasis but also pave the way for more personalized, non-invasive diagnostic tools in oncology. Reference: 1. Verma, H.K., et al., A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy. Curr Drug Metab, 2019. 20(12): p. 958-966. 2. Golivi, Y., et al., Small molecular inhibitors: Therapeutic strategies for pancreatic cancer. Drug Discovery Today, 2024. 29(7): p. 104053. 3. Wu, J. and Z. Shen, Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer. Cancer Med, 2020. 9(19): p. 6909-6922. 4. Lohajová Behulová, R., et al., Circulating exosomal miRNAs as a promising diagnostic biomarker in cancer. Physiol Res, 2023. 72(S3): p. S193-s207. 5. Li, C., et al., The role of Exosomal miRNAs in cancer. Journal of Translational Medicine, 2022. 20(1): p. 6. 6. Uddin, M.H., et al., Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside. Cancers (Basel), 2021. 13(11). 7. Jafari, A., et al., The Emerging Role of Exosomal miRNAs as Biomarkers for Early Cancer Detection: A Comprehensive Literature Review. Technol Cancer Res Treat, 2023. 22: p. 15330338231205999. 8. Xu, Y., et al., The role of exosomal microRNAs in pancreatic cancer. Stem Cell Investigation, 2020. 7. 9. Gilles, M.E. and F.J. Slack, Let-7 microRNA as a potential therapeutic target with implications for immunotherapy. Expert Opin Ther Targets, 2018. 22(11): p. 929-939. 10. Ma, Q., et al., HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition. Front Oncol, 2024. 14: p. 1320887. 11. Valera, V.A., et al., microRNA Expression Profiling in Young Prostate Cancer Patients. J Cancer, 2020. 11(14): p. 4106-4114. 12. Chen, C., L. Demirkhanyan, and C.S. Gondi, The Multifaceted Role of miR-21 in Pancreatic Cancers. Cells, 2024. 13(11). 13. Yuan, W., et al., New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer. Oncotarget, 2016. 7(48). "  [Collapse]
Ren S, Song LN, Zhao R, Tian Y, Wang ZQ. Serum exosomal hsa-let-7f-5p: A potential diagnostic biomarker for metastatic pancreatic cancer detection. World J Gastroenterol 2025; 31(26): 109500
12
"This paper provides an interesting exploration of Chinese medicine monomers in regulating autophagy for the prevention and treatment ..."  [Read more]
"This paper provides an interesting exploration of Chinese medicine monomers in regulating autophagy for the prevention and treatment of HCC. The review highlights the potential of various compounds in modulating key signaling pathways involved in autophagy, offering new insights into the development of therapeutic strategies for HCC. The integration of traditional Chinese medicine with modern pharmacology is an exciting approach that could open up novel treatment avenues for cancer. However, the study mainly focuses on preclinical findings, and the lack of clinical trial data limits its immediate application. Despite this, the research is highly relevant for both basic and clinical oncology, offering promising directions for future studies and therapeutic development. "  [Collapse]
Zheng SH, Xue TY, Wang QY, Ye YA, Zhang P. Chinese medicine monomers for hepatocellular carcinoma: New ideas related to autophagy. World J Gastroenterol 2025; 31(26): 106113
13
"This paper provides valuable insights into the potential of endocytoscopy as a real-time diagnostic tool for UC. The study highlights ..."  [Read more]
"This paper provides valuable insights into the potential of endocytoscopy as a real-time diagnostic tool for UC. The study highlights the effectiveness of the ECSS and ELECT score in assessing both endoscopic and histological activity. The findings suggest that endocytoscopy can offer a faster, non-invasive alternative to traditional histopathological methods, potentially improving clinical decision-making in UC management. However, the study is limited by its small sample size and single-center design, which may affect the generalizability of the results. Despite these limitations, the paper shows the promising role of endocytoscopy in assessing UC activity, with potential implications for more efficient and timely disease management in clinical practice. "  [Collapse]
Chaemsupaphan T, Shir Ali M, Fung C, Paramsothy S, Leong RW. Endocytoscopy in real-time assessment of histological and endoscopic activity in ulcerative colitis. World J Gastrointest Endosc 2025; 17(7): 108082
14
"This paper provides valuable insights into the complementary roles of VCE and SBE in diagnosing small bowel disorders. By comparing ..."  [Read more]
"This paper provides valuable insights into the complementary roles of VCE and SBE in diagnosing small bowel disorders. By comparing both techniques, the study highlights VCE’s superiority for non-invasive initial evaluations and SBE’s utility in therapeutic interventions and obtaining histopathological confirmation. The findings are clinically significant, especially in managing obscure gastrointestinal bleeding and small bowel tumors, offering a more structured approach for clinicians. However, the study could benefit from a discussion on emerging technologies and larger, prospective studies to further validate its findings. Overall, this paper is a useful reference for clinicians involved in small bowel diagnostics. "  [Collapse]
Gadour E, Miutescu B, Okasha HH, Ghiuchici AM, AlQahtani MS. Diagnostic yield of video capsule endoscopy vs simple balloon enteroscopy in small intestinal disorders: A systematic review. World J Gastrointest Endosc 2025; 17(7): 108264
15
"### Review of the Article “Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis, and inflammation in ..."  [Read more]
"### Review of the Article “Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis, and inflammation in metabolic dysfunction-associated steatotic liver disease” published in the World Journal of Gastroenterology This article represents a significant advancement in the non-invasive diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) and offers valuable insights for clinical practice. #### Clinical Application Value The study introduces a non-invasive assessment method based on multiparametric ultrasound, which holds great significance for clinical practice. Given the large number of MASLD patients, traditional liver biopsy is not only costly but also associated with sampling errors and risks of complications. The introduction of multiparametric ultrasound provides clinicians with a safer and more convenient diagnostic tool, effectively reducing the need for liver biopsies and minimizing patient discomfort and medical costs. #### Innovation For the first time, this study compares viscosity measurements (Vi.PLUS) with the histopathological features of MASLD and finds that viscosity is closely related to the degree of inflammation and ballooning in MASH. This finding offers a new perspective for the non-invasive diagnosis of MASLD and paves the way for future research and clinical applications. #### Methodological Rigor The study employs a single-center, prospective, cross-sectional design with 120 patients, all of whom underwent liver biopsy as the reference standard. This rigorous study design and methodology ensure the reliability and scientific validity of the results. #### Practicality of the Results The study demonstrates that the VAS-MASH-US score, based on multiparametric ultrasound, has good sensitivity and specificity for diagnosing MASH. This scoring system provides clinicians with a practical tool to better identify high-risk patients who need liver biopsy, while reducing unnecessary invasive examinations for low-risk patients. #### Limitations of the Study Despite the significant findings, the study has some limitations. For example, it is a single-center study with a relatively small sample size, and the results have not yet been validated in an independent cohort. Additionally, differences in ultrasound equipment and techniques across centers may affect the generalizability of the results. #### Implications for Future Research This study provides new ideas and methods for the non-invasive diagnosis of MASLD, but further research is needed to validate these findings. For instance, multicenter studies in larger populations could verify the universality and accuracy of the VAS-MASH-US score. Moreover, exploring the combination of other non-invasive techniques with multiparametric ultrasound could further improve the diagnostic accuracy of MASLD. In summary, this article represents an important step forward in the non-invasive diagnosis of MASLD. Its innovation and practicality are commendable. It is hoped that more research will be conducted in the future to further refine this field and provide better medical services for MASLD patients. "  [Collapse]
Liguori A, Ainora ME, Di Gialleonardo L, Viceconti N, Petrucci L, Esposto G, Giustiniani MC, Mignini I, Borriello R, Galasso L, Paratore M, Garcovich M, Riccardi L, Pompili M, Grieco A, Gasbarrini A, Miele L, Zocco MA. Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis, and inflammation in metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2025; 31(25): 105518
16
"Good case report of involvement of thyroid cartilage, however, it is a very rare incidence. Language quality is good. Content is ok ..."  [Read more]
"Good case report of involvement of thyroid cartilage, however, it is a very rare incidence. Language quality is good. Content is ok IHC report images should also be included to solidify the diagnosis and not just mentioning the report of IHC findings. Study stated to look for the distant metastasis including the thyroid/cartilage. However, hematogenous spread to more common distant organ should be more focused on rather than the rare ones. Especially-- liver, bone etc. Metastasis to thyroid cartilage- a poor prognostic factor--mentioned in the study. However, could not get any information/data for that "  [Collapse]
Ai MM, Lin T, Guo RY, Zhang YY, Yu F. Unexpected metastasis of thyroid cartilage involvement from lung adenocarcinoma: A case report. World J Clin Cases 2025; 13(25): 107471
17
"Good case report of involvement of thyroid cartilage, however, it is a very rare incidence. Language quality is good. Content is ok ..."  [Read more]
"Good case report of involvement of thyroid cartilage, however, it is a very rare incidence. Language quality is good. Content is ok IHC report images should also be included to solidify the diagnosis and not just mentioning the report of IHC findings. Study stated to look for the distant metastasis including the thyroid/cartilage. However, hematogenous spread to more common distant organ should be more focused on rather than the rare ones. Especially-- liver, bone etc. Metastasis to thyroid cartilage- a poor prognostic factor--mentioned in the study. However, could not get any information/data for that. "  [Collapse]
Ma TT, Lyu HR. Post-endoscopic retrograde appendicitis therapy stent impaction leading to exacerbation of appendicitis: A case report. World J Clin Cases 2025; 13(25): 106587
18
"tertiary care hospital over the last 7 years from the Himalayan and Sub-Himalayan regions of India. Studys aim--To analyze the ..."  [Read more]
"tertiary care hospital over the last 7 years from the Himalayan and Sub-Himalayan regions of India. Studys aim--To analyze the demography, clinical presentation, complications, and mortality risk factors in presumptive leptospirosis patients admitted--- was fulfilled, however, limited to one single center study and observation only. 2018-2024 data were collected based on Modified Faine’s criteria with ELISA diagnosis. \ Sample size is small. 62 number Study found- equal number of distribution of cases irrespective of sex. Complications include thrombocytopenia and liver involvement and AKI. MDS was serious complication observed in 66% of cases. Studies have also highlighted that early administration of antibiotics and aggressive supportive care can improve survival outcomes in critically ill patients with leptospirosis Limitation—only single center study with possible some selection bias. Overall Language quality and content-- Excellent. "  [Collapse]
Das D, Ponnampurathu S, Panda PK, Mathuria YP. Different clinical profile of leptospirosis in a tertiary care Indian hospital: A Himalayan experience. World J Clin Cases 2025; 13(25): 106335
19
"Study conducted from 1985 to 2022--total 47 patients included with PDTC. some of them lost on follow up. Good analysis of risk factors ..."  [Read more]
"Study conducted from 1985 to 2022--total 47 patients included with PDTC. some of them lost on follow up. Good analysis of risk factors and outcome. Good standard of article The scientific quality of very good The language quality is also professional and clear. The data analysis and charts are upto the mark. "  [Collapse]
Hsu CW, Hsueh C, Lu YL, Hsu CJ, Wong RJ, Lin SF. Risk factors and outcomes of metastatic poorly differentiated thyroid carcinoma. World J Clin Cases 2025; 13(25): 105204
20
"This paper reports on a clinical trial assessing the efficacy and safety of sirolimus in the treatment of gastrointestinal ..."  [Read more]
"This paper reports on a clinical trial assessing the efficacy and safety of sirolimus in the treatment of gastrointestinal angiodysplasia (GIAD). The results indicate that sirolimus is effective in reducing bleeding, improving hemoglobin levels, decreasing transfusion dependence, and improving lesion outcomes. Additionally, the adverse effects were mild and manageable. However, it should be noted that while patients with various underlying conditions were included, those with chronic kidney disease were not represented. This is a concern, as patients with chronic kidney disease often experience recurrent gastrointestinal bleeding due to angiodysplasia. Further studies involving a larger number of patients, including those with chronic kidney disease, are warranted. "  [Collapse]
Sun Q, Wu JC, Chen X, Li DH, Li BR, Xiao NJ, Wang XY, Tu XZ, Ning SB, Sun T. Efficacy and safety of sirolimus in the treatment of gastrointestinal angiodysplasias. World J Gastroenterol 2025; 31(25): 105677
1014 items  Read more >>
Write to the Help Desk
  • ALL AUTHOR RESOURCES
  • Appeals and Complaints
  • Article Processing Charge
  • Common Usage of Quantities and Units
  • Copyright License Agreement
  • Create an Account
  • Criteria for Authorship
  • Ethics Committee of BPG
  • Ethics Statements
  • Guidelines for Authors
  • Journals
  • Language Editing Process for Manuscripts Submitted by Non-Native Speakers of English
  • Methods of Post-Publication Debate
  • Open-Access
  • Policies on Handle Allegations from Whistleblowers
  • Publication Misconduct
  • Quality of Publications
  • Steps for Submitting Manuscripts
  • Submit a Manuscript
  • ALL PEER-REVIEWER RESOURCES
  • Manuscript Decision
  • Peer-Review Process
  • Peer-Reviewer Tracking for Manuscripts
  • Reviewer Acknowledgment
  • REFERENCE CITATION ANALYSIS
  • Find a Category
  • Find a Journal
  • Find a Scholar
  • Find an Academic Assistant
  • Find an Article
  • Find an Article PDF
  • Subscribe
  • Today's Articles
  • ALL PUBLISHER RESOURCES
  • About the BPG
  • BPG Home
  • Company Registration
  • Contact Us
  • ICMJE Conformity
  • Management Team
  • Membership
  • Ownership
  • Permissions
  • Privacy Policy
  • Publication Ethics
  • Publisher
  • Publishing Credentials
  • Revenue Sources
  • Special Statement
  • Terms of Use
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345